Investor Dossier
eureKARE
active
Typeinvestor
SectorBioTech
LocationParis
Portfolio (3 investments)
Coave Therapeutics
Series B · Jul 2021
LEAD
€33.0M
DNA Script
Series C · Jan 2022
€33.3M
Biomemory
Seed · Nov 2022
€5.0M
Funding Lineage
Series A
0 investors
€51.0M
May 2021